Geode Capital Management
BMY icon

Geode Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Geode Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.34B Buy
55,286,174
+2,647,828
+5% +$154M 0.21% 75
2025
Q4 		$2.84B Buy
52,638,346
+6,084,046
+13% +$293M 0.18% 90
2025
Q3 		$2.1B Buy
46,554,300
+377,610
+0.8% +$17.6M 0.13% 122
2025
Q2 		$2.13B Buy
46,176,690
+723,459
+2% +$35.5M 0.15% 111
2025
Q1 		$2.77B Buy
45,453,231
+1,061,984
+2% +$61.9M 0.22% 83
2024
Q4 		$2.51B Buy
44,391,247
+1,187,231
+3% +$66.3M 0.19% 85
2024
Q3 		$2.23B Buy
43,204,016
+1,036,495
+2% +$48.6M 0.18% 96
2024
Q2 		$1.75B Buy
42,167,521
+862,916
+2% +$38.6M 0.15% 112
2024
Q1 		$2.23B Buy
41,304,605
+1,627,500
+4% +$82.9M 0.21% 85
2023
Q4 		$2.03B Sell
39,677,105
-25,942
-0.1% -$1.36M 0.21% 86
2023
Q3 		$2.3B Buy
39,703,047
+668,706
+2% +$41M 0.27% 58
2023
Q2 		$2.49B Buy
39,034,341
+225,065
+0.6% +$15.1M 0.29% 54
2023
Q1 		$2.68B Buy
38,809,276
+85,162
+0.2% +$6.01M 0.35% 49
2022
Q4 		$2.78B Sell
38,724,114
-423,021
-1% -$31.9M 0.39% 44
2022
Q3 		$2.78B Buy
39,147,135
+1,131,303
+3% +$82.1M 0.42% 38
2022
Q2 		$2.92B Buy
38,015,832
+454,368
+1% +$34.6M 0.43% 39
2022
Q1 		$2.74B Sell
37,561,464
-301,635
-0.8% -$20.3M 0.34% 50
2021
Q4 		$2.35B Buy
37,863,099
+922,811
+2% +$54.1M 0.28% 61
2021
Q3 		$2.18B Buy
36,940,288
+982,470
+3% +$64.7M 0.29% 62
2021
Q2 		$2.4B Buy
35,957,818
+1,354,869
+4% +$88.3M 0.33% 52
2021
Q1 		$2.18B Buy
34,602,949
+575,652
+2% +$35.8M 0.33% 56
2020
Q4 		$2.11B Buy
34,027,297
+297,655
+0.9% +$18.3M 0.35% 51
2020
Q3 		$2.03B Buy
33,729,642
+772,282
+2% +$46.5M 0.4% 45
2020
Q2 		$1.93B Sell
32,957,360
-7,276,641
-18% -$435M 0.41% 43
2020
Q1 		$2.24B Buy
40,234,001
+1,796,244
+5% +$110M 0.58% 31
2019
Q4 		$2.46B Buy
38,437,757
+11,012,994
+40% +$631M 0.51% 31
2019
Q3 		$1.39B Buy
27,424,763
+1,738,638
+7% +$81.7M 0.32% 58
2019
Q2 		$1.16B Buy
25,686,125
+1,522,093
+6% +$70.9M 0.28% 67
2019
Q1 		$1.15B Buy
24,164,032
+3,847,693
+19% +$192M 0.3% 62
2018
Q4 		$1.05B Sell
20,316,339
-196,511
-1% -$10.6M 0.33% 61
2018
Q3 		$1.27B Buy
20,512,850
+337,536
+2% +$20M 0.36% 54
2018
Q2 		$1.11B Buy
20,175,314
+388,721
+2% +$21M 0.34% 55
2018
Q1 		$1.25B Buy
19,786,593
+1,203,124
+6% +$77.4M 0.41% 46
2017
Q4 		$1.14B Buy
18,583,469
+777,929
+4% +$48.7M 0.39% 47
2017
Q3 		$1.13B Buy
17,805,540
+338,317
+2% +$19.8M 0.42% 46
2017
Q2 		$972M Buy
17,467,223
+399,850
+2% +$21.8M 0.38% 46
2017
Q1 		$927M Buy
17,067,373
+1,295,545
+8% +$71.1M 0.38% 49
2016
Q4 		$921M Buy
15,771,828
+1,681,647
+12% +$91.9M 0.43% 42
2016
Q3 		$759M Buy
14,090,181
+650,041
+5% +$41.8M 0.38% 48
2016
Q2 		$987M Sell
13,440,140
-94,435
-0.7% -$6.67M 0.54% 36
2016
Q1 		$863K Buy
13,534,575
+254,653
+2% +$16.1M 0.46% 43
2015
Q4 		$912M Buy
13,279,922
+6,576
+0% +$435K 0.52% 36
2015
Q3 		$784M Buy
13,273,346
+48,489
+0.4% +$3.08M 0.48% 38
2015
Q2 		$878M Buy
13,224,857
+309
+0% +$20.4K 0.5% 38
2015
Q1 		$852M Buy
13,224,548
+429,157
+3% +$26.9M 0.49% 39
2014
Q4 		$754M Buy
12,795,391
+415,808
+3% +$23.4M 0.45% 43
2014
Q3 		$633M Sell
12,379,583
-54,035
-0.4% -$2.7M 0.41% 45
2014
Q2 		$603M Buy
12,433,618
+254,064
+2% +$12.5M 0.39% 48
2014
Q1 		$632M Buy
12,179,554
+63,175
+0.5% +$3.36M 0.42% 43
2013
Q4 		$644M Buy
12,116,379
+428,148
+4% +$21.8M 0.45% 42
2013
Q3 		$541M Buy
11,688,231
+380,573
+3% +$16.7M 0.43% 40
2013
Q2 		$505M Buy
+11,307,658
New +$491M 0.44% 38

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management's BMY Position: Q1 2026 in Review

Geode Capital Management increased its Bristol-Myers Squibb (BMY) stake by 5% in Q1 2026, buying an estimated $154M and bringing the position to 55,286,174 shares worth $3.34B. The position accounts for 0.21% of the portfolio, ranked #75.

Geode Capital Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Geode Capital Management held 55,286,174 shares of Bristol-Myers Squibb worth $3.34B as of Q1 2026.
  • Geode Capital Management bought 2,647,828 Bristol-Myers Squibb shares in Q1 2026, an estimated $154M.
  • Bristol-Myers Squibb made up 0.21% of Geode Capital Management's portfolio in Q1 2026, its #75 holding.
  • Geode Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.